305 related articles for article (PubMed ID: 24813368)
1. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
3. Bo's abdominal acupuncture improves disordered metabolism in obese type 2 diabetic rats through regulating fibroblast growth factor 21 and its related adipokines.
Xihui Q; Jianli P; Guan X; Jie F
J Tradit Chin Med; 2023 Oct; 43(6):1200-1208. PubMed ID: 37946482
[TBL] [Abstract][Full Text] [Related]
4. Hepatic-Specific FGF21 Knockout Abrogates Ovariectomy-Induced Obesity by Reversing Corticosterone Production.
Xu J; Shao X; Zeng H; Wang C; Li J; Peng X; Zhuo Y; Hua L; Meng F; Han X
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834368
[TBL] [Abstract][Full Text] [Related]
5. BetaKlotho is required for metabolic activity of fibroblast growth factor 21.
Ogawa Y; Kurosu H; Yamamoto M; Nandi A; Rosenblatt KP; Goetz R; Eliseenkova AV; Mohammadi M; Kuro-o M
Proc Natl Acad Sci U S A; 2007 May; 104(18):7432-7. PubMed ID: 17452648
[TBL] [Abstract][Full Text] [Related]
6. Metformin Improves the Prerequisites for FGF21 Signaling in Patients With Type 2 Diabetes.
Pedersen AKN; Gormsen LC; Nielsen S; Jessen N; Bjerre M
J Clin Endocrinol Metab; 2024 Jan; 109(2):e552-e561. PubMed ID: 37776319
[TBL] [Abstract][Full Text] [Related]
7. Molecular adaptations of adipose tissue to 6 weeks of morning fasting vs. daily breakfast consumption in lean and obese adults.
Gonzalez JT; Richardson JD; Chowdhury EA; Koumanov F; Holman GD; Cooper S; Thompson D; Tsintzas K; Betts JA
J Physiol; 2018 Feb; 596(4):609-622. PubMed ID: 29193093
[TBL] [Abstract][Full Text] [Related]
8. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19).
Wu X; Ge H; Lemon B; Vonderfecht S; Baribault H; Weiszmann J; Gupte J; Gardner J; Lindberg R; Wang Z; Li Y
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14158-63. PubMed ID: 20660733
[TBL] [Abstract][Full Text] [Related]
9. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.
Goetz R; Ohnishi M; Kir S; Kurosu H; Wang L; Pastor J; Ma J; Gai W; Kuro-o M; Razzaque MS; Mohammadi M
J Biol Chem; 2012 Aug; 287(34):29134-46. PubMed ID: 22733815
[TBL] [Abstract][Full Text] [Related]
10. Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis.
Zangerolamo L; Carvalho M; Velloso LA; Barbosa HCL
Eur J Pharmacol; 2024 Jan; 963():176248. PubMed ID: 38056616
[TBL] [Abstract][Full Text] [Related]
11. Ileal Transposition Surgery Decreases Fat Mass and Improves Glucose Metabolism in Diabetic GK Rats: Possible Involvement of FGF21.
Yan K; Chen W; Zhu H; Lin G; Pan H; Li N; Wang L; Yang H; Liu M; Gong F
Front Physiol; 2018; 9():191. PubMed ID: 29593555
[No Abstract] [Full Text] [Related]
12. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
Ghanem M; Archer G; Crestani B; Mailleux AA
Pharmacol Ther; 2024 Jul; 259():108669. PubMed ID: 38795981
[TBL] [Abstract][Full Text] [Related]
13. A liver stress-endocrine nexus promotes metabolic integrity during dietary protein dilution.
Maida A; Zota A; Sjøberg KA; Schumacher J; Sijmonsma TP; Pfenninger A; Christensen MM; Gantert T; Fuhrmeister J; Rothermel U; Schmoll D; Heikenwälder M; Iovanna JL; Stemmer K; Kiens B; Herzig S; Rose AJ
J Clin Invest; 2016 Sep; 126(9):3263-78. PubMed ID: 27548521
[TBL] [Abstract][Full Text] [Related]
14. The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review.
Sadowska A; Poniedziałek-Czajkowska E; Mierzyński R
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139126
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.
Braun LR; Feldpausch MN; Czerwonka N; Torriani M; Grinspoon SK; Stanley TL
Growth Horm IGF Res; 2017 Dec; 37():1-6. PubMed ID: 29031905
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 and its novel association with oxidative stress.
Gómez-Sámano MÁ; Grajales-Gómez M; Zuarth-Vázquez JM; Navarro-Flores MF; Martínez-Saavedra M; Juárez-León ÓA; Morales-García MG; Enríquez-Estrada VM; Gómez-Pérez FJ; Cuevas-Ramos D
Redox Biol; 2017 Apr; 11():335-341. PubMed ID: 28039838
[TBL] [Abstract][Full Text] [Related]
17. The cooperation of FGF receptor and Klotho is involved in excretory canal development and regulation of metabolic homeostasis in Caenorhabditis elegans.
Polanska UM; Edwards E; Fernig DG; Kinnunen TK
J Biol Chem; 2011 Feb; 286(7):5657-66. PubMed ID: 21177529
[TBL] [Abstract][Full Text] [Related]
18. FGF19 Promotes the Proliferation and Insulin Secretion from Human Pancreatic β Cells Via the IRS1/GLUT4 Pathway.
Zeng T; Tang X; Bai X; Xiong H
Exp Clin Endocrinol Diabetes; 2024 Mar; 132(3):152-161. PubMed ID: 38513652
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of a fat-directed FGF21 gene therapy in aged female mice.
Anderson JM; Arnold WD; Huang W; Ray A; Owendoff G; Cao L
Gene Ther; 2024 Mar; 31(3-4):95-104. PubMed ID: 37699965
[TBL] [Abstract][Full Text] [Related]
20. Impaired Fibroblast Growth Factor 21 (FGF21) Associated with Visceral Adiposity Leads to Insulin Resistance: The Core Defect in Diabetes Mellitus.
Jain U; Srivastava P; Sharma A; Sinha S; Johari S
Curr Diabetes Rev; 2024 Apr; ():. PubMed ID: 38676505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
